Atypical small acinar proliferation in the prostate: Clinical significance in 2006

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 7, 2006, Pages 952-957

  Bostwick, David G ^a   Meiers, Isabelle ^a  

^a BOSTWICK LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACINAR CELL; ACINAR CELL CARCINOMA; ATYPICAL SMALL ACINAR PROLIFERATION; CANCER DIAGNOSIS; CELL PROLIFERATION; HUMAN; INVASIVE CARCINOMA; NEEDLE BIOPSY; PROSTATE BIOPSY; PROSTATE CANCER; REVIEW;

ADENOCARCINOMA; BIOPSY, NEEDLE; CELL PROLIFERATION; DIAGNOSIS, DIFFERENTIAL; FOLLOW-UP STUDIES; HUMANS; MALE; PRECANCEROUS CONDITIONS; PROSTATE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 33745934819     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Borboroglu PG, Sur RL, Roberts JL, Amling CL. Repeat biopsy strategy in patients with atypical small acinar proliferation or high grade prostatic intraepithelial neoplasia on initial prostate needle biopsy. J Urol. 2001;166:866-870.
2. Cheville JC, Reznicek MJ, Bostwick DG. The focus of "atypical glands, suspicious for malignancy" in prostatic needle biopsy specimens: incidence, histologic features, and clinical follow-up of cases diagnosed in a community practice. Am J Clin Pathol. 1997;108:633-640.
3. Iczkowski KA, Bassler TJ, Schwob VS, et al. Diagnosis of "suspicious for malignancy" in prostate biopsies: predictive value for cancer. Urology. 1998;51:749-757, discussion 757-758.
4. Iczkowski KA, MacLennan GT, Bostwick DG. Atypical small acinar proliferation suspicious for malignancy in prostate needle biopsies: clinical significance in 33 cases. Am J Surg Pathol. 1997;21:1489-1495.
5. Scattoni V, Roscigno M, Freschi M, et al. Atypical small acinar proliferation (ASAP) on extended prostatic biopsies: predictive factors of cancer detection on repeat biopsies. Arch Ital Urol Androl. 2005;77:31-36.
6. Chan TY, Epstein JI. Follow-up of atypical prostate needle biopsies suspicious for cancer. Urology. 1999;53:351-355.
7. Renshaw AA, Santis WF, Richie JP. Clinicopathological characteristics of prostatic adenocarcinoma in men with atypical prostate needle biopsies. J Urol. 1998;159:2018-2021, discussion 2022.
8. Park S, Shinohara K, Grossfeld GD, Carroll PR. Prostate cancer detection in men with prior high-grade prostatic intraepithelial neoplasia or atypical prostate biopsy. J Urol. 2001;165:1409-1414.
9. Iczkowski KA, Casella G, Seppala RJ, et al. Needle core length in sextant biopsy influences prostate cancer detection rate. Urology. 2002;59:698-703.
10. Iczkowski KA, Bostwick DG. Prostate biopsy interpretation: current concepts, 1999. Urol Clin North Am. 1999;26:435-452.
11. Iczkowski KA, Bostwick DG. Criteria for biopsy diagnosis of minimal volume prostatic adenocarcinoma: analytic comparison with nondiagnostic but suspicious atypical small acinar proliferation. Arch Pathol Lab Med. 2000;124:98-107.
12. Ro JY, Grignon DJ, Troncoso P, Ayala AG. Mucin in prostatic adenocarcinoma. Semin Diagn Pathol. 1988;5:273-283.
13. Del Rosario AD, Bui HX, Abdulla M, Ross JS. Sulfur-rich prostatic intraluminal crystalloids: a surgical pathologic and electron probe x-ray microanalytic study. Hum Pathol. 1993;24:1159-1167.
14. Bostwick DG, Srigley J, Grignon D, et al. Atypical adenomatous hyperplasia of the prostate: morphologic criteria for its distinction from well-differentiated carcinoma. Hum Pathol. 1993;24:819-832.
15. Anton RC, Chakraborty S, Wheeler TM. The significance of intraluminal prostatic crystalloids in benign needle biopsies. Am J Surg Pathol. 1998;22:446-449.
16. Henneberry JM, Kahane H, Humphrey PA, Keetch DW, Epstein JI. The significance of intraluminal crystalloids in benign prostatic glands on needle biopsy. Am J Surg Pathol. 1997;21:725-728.
17. Cheville JC, Bostwick DG. Postatrophic hyperplasia of the prostate: a histologic mimic of prostatic adenocarcinoma. Am J Surg Pathol. 1995;19:1068-1076.
18. Iczkowski KA, Chen HM, Yang XJ, Beach RA. Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy. Urology. 2002;60:851-854.
19. Fadare O, Wang S, Mariappan MR. Practice patterns of clinicians following isolated diagnoses of atypical small acinar proliferation on prostate biopsy specimens. Arch Pathol Lab Med. 2004;128:557-560.
20. Schlesinger C, Bostwick DG, Iczkowski KA. High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: predictive value for cancer in current practice. Am J Surg Pathol. 2005;29:1201-1207.
21. Walsh PC. Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy. J Urol. 2003;170:316.
22. Rabbani F, Stroumbakis N, Kava BR, Cookson MS, Fair WR. Incidence and clinical significance of false-negative sextant prostate biopsies. J Urol. 1998;159:1247-1250.
23. DiGiuseppe JA, Sauvageot J, Epstein JI. Increasing incidence of minimal residual cancer in radical prostatectomy specimens. Am J Surg Pathol. 1997;21(2):174-178.
24. Brausi M, Castagnetti G, Dotti A, De Luca G, Olmi R, Cesinaro AM. Immediate radical prostatectomy in patients with atypical small acinar proliferation: over treatment? J Urol. 2004;172:906-908, discussion 908-909.
25. Shah RB, Zhou M, LeBlanc M, Snyder M, Rubin MA. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol. 2002;26:1161-1168.
26. Browne TJ, Hirsch MS, Brodsky G, Welch WR, Loda MF, Rubin MA. Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens. Hum Pathol. 2004;35:1462-1468.
27. Jiang Z, Woda BA. Diagnostic utility of alpha-methylacyl CoA racemase (P504S) on prostate needle biopsy. Adv Anat Pathol. 2004;11:316-321.
28. Molinie V, Fromont G, Sibony M, et al. Diagnostic utility of a p63/alpha-methyl-CoA-racemase (p504s) cocktail in atypical foci in the prostate. Mod Pathol. 2004;17:1180-1190.
29. Shah RB, Kunju LP, Shen R, LeBlanc M, Zhou M, Rubin MA. Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferations. Am J Clin Pathol. 2004;122:517-523.
30. Kronz JD, Shaikh AA, Epstein JI. High-grade prostatic intraepithelial neoplasia with adjacent small atypical glands on prostate biopsy. Hum Pathol. 2001;32:389-395.
31. Alsikafi NF, Brendler CB, Gerber GS, Yang XJ. High-grade prostatic intraepithelial neoplasia with adjacent atypia is associated with a higher incidence of cancer on subsequent needle biopsy than high-grade prostatic intraepithelial neoplasia alone. Urology. 2001;57:296-300.
32. Epstein JI. Diagnostic criteria of limited adenocarcinoma of the prostate on needle biopsy. Hum Pathol. 1995;26:223-229.